PETS
NASDAQPetMed Express Inc.
SectorConsumer StaplesIndustryRetail-Drug Stores and Proprietary Stores
Website
News25/Ratings6
News · 26 weeks25+100%
2025-10-262026-04-19
Mix290d
- SEC Filings1(50%)
- Other1(50%)
Latest news
25 items- PRPetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channelsDELRAY BEACH, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., doing business as PetMeds and parent company of PetCareRx (NASDAQ:PETS), today announced a strategic partnership with Rural King to launch a new pet pharmacy offering, expanding access to prescription medications, preventatives and pet health products for customers across Rural King's retail stores and digital platforms. Through the partnership, PetMeds will provide pharmacy infrastructure, licensed pharmacists and e-commerce capabilities to enable Rural King customers to conveniently access trusted medications and health solutions for their animals. The collaboration marks PetMeds' first large-scale white-label
- SECSEC Form 10-Q filed by PetMed Express Inc.10-Q - PETMED EXPRESS INC (0001040130) (Filer)
- INSIDERDirector Fulgoni Gian returned 26,057 shares to the company, decreasing direct ownership by 16% to 132,299 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- SECPetMed Express Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - PETMED EXPRESS INC (0001040130) (Filer)
- SECAmendment: PetMed Express Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K/A - PETMED EXPRESS INC (0001040130) (Filer)
- SECSEC Form 10-Q filed by PetMed Express Inc.10-Q - PETMED EXPRESS INC (0001040130) (Filer)
- SECSEC Form 10-Q filed by PetMed Express Inc.10-Q - PETMED EXPRESS INC (0001040130) (Filer)
- PRCardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed ExpressCardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non-binding proposal to acquire PetMed Express, Inc. (NASDAQ:PETS) ("PetMeds") for $4.25 per share in cash, representing an implied equity value of approximately $89 million. The proposal was delivered to the Board of Directors of PetMed Express and is not subject to any financing contingency, reflecting Cardone Ventures' confidence in its ability to execute the transaction. Strategic Rationale Cardone Ventures views PetMeds as a strategically important acquisition that aligns with its core mission of acquiring, operat
- PRPetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments LimitedDELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company" or "PetMeds"), today confirmed that it has received an unsolicited and non-binding acquisition proposal from SilverCape Investments Limited, a Singapore-based investment firm, to acquire all of the outstanding shares of the Company for $4 per share in cash, subject to various conditions such as due diligence and the execution of a mutually acceptable definitive agreement, but not subject to any financing contingency. While PetMeds would typically not publicly comment on privately submitted and non-binding acquisition proposals, SilverCape h
- SECSEC Form DEF 14A filed by PetMed Express Inc.DEF 14A - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love ThemDELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company"), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, PetMeds' giftable assortment focuses on products that improve pets' everyday health, comfort, safety, and happiness, making them ideal for the pet owner who has everything. "With more pet parents treating their furry friends like true members of the family, holiday gifting has shifted toward smart, we
- SECPetMed Express Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- SECAmendment: SEC Form 8-A12B/A filed by PetMed Express Inc.8-A12B/A - PETMED EXPRESS INC (0001040130) (Filer)
- SECPetMed Express Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Leadership Update, Other Events, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMeds Extends Existing Shareholder Rights PlanDELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company"), today announced that its Board of Directors (the "Board") has unanimously approved an amendment to the Company's existing shareholder rights plan (the "Rights Plan"), pursuant to which the expiration date of the Rights was extended for one year from the close of business on December 2, 2025 until the close of business on December 2, 2026. All other terms and conditions of the Rights Plan remain unchanged. The Board adopted the Rights Plan to protect the investment of shareholders during a period in which it believes shares of the Company
- INSIDERDirector Fulgoni Gian was granted 33,846 shares, increasing direct ownership by 27% to 158,356 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- SECPetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from NasdaqDELRAY BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company"), today announced preliminary second quarter fiscal year 2026 results and filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Form 10-Q for the quarter ended September 30, 2025 within the prescribed time period without unreasonable effort or expense. Preliminary Second Quarter Net Sales: For the fiscal second quarter ended September 30, 2025, net sales are estimated to range from $43.4 million to $44.5 million compared to $58.0 million (as restated) in the prior y
- SECSEC Form NT 10-Q filed by PetMed Express Inc.NT 10-Q - PETMED EXPRESS INC (0001040130) (Filer)
- INSIDERCAO and Interim CFO Krulik Douglas was granted 20,000 shares, increasing direct ownership by 40% to 70,000 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- INSIDERDirector Lacamp James was granted 34,866 shares (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- INSIDERDirector Mennen Justin L. was granted 33,846 shares, increasing direct ownership by 381% to 42,719 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- INSIDERDirector Solivan Leah was granted 33,846 shares, increasing direct ownership by 401% to 42,289 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- INSIDERDirector Batushansky Peter was granted 33,846 shares, increasing direct ownership by 1,339% to 36,373 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lacamp James3 - PETMED EXPRESS INC (0001040130) (Issuer)